AU2001261423A1 - Vasodilator-thrombolytic fusion proteins and conjugates - Google Patents

Vasodilator-thrombolytic fusion proteins and conjugates

Info

Publication number
AU2001261423A1
AU2001261423A1 AU2001261423A AU6142301A AU2001261423A1 AU 2001261423 A1 AU2001261423 A1 AU 2001261423A1 AU 2001261423 A AU2001261423 A AU 2001261423A AU 6142301 A AU6142301 A AU 6142301A AU 2001261423 A1 AU2001261423 A1 AU 2001261423A1
Authority
AU
Australia
Prior art keywords
vasodilator
conjugates
fusion proteins
thrombolytic
thrombolytic fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261423A
Inventor
Ethan Lerner
Vemuri B. Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2001261423A1 publication Critical patent/AU2001261423A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
AU2001261423A 2000-05-11 2001-05-10 Vasodilator-thrombolytic fusion proteins and conjugates Abandoned AU2001261423A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56992000A 2000-05-11 2000-05-11
US09569920 2000-05-11
PCT/US2001/015209 WO2001085100A2 (en) 2000-05-11 2001-05-10 Vasodilator-thrombolytic fusion proteins and conjugates

Publications (1)

Publication Number Publication Date
AU2001261423A1 true AU2001261423A1 (en) 2001-11-20

Family

ID=24277454

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261423A Abandoned AU2001261423A1 (en) 2000-05-11 2001-05-10 Vasodilator-thrombolytic fusion proteins and conjugates

Country Status (2)

Country Link
AU (1) AU2001261423A1 (en)
WO (1) WO2001085100A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
JP7183164B2 (en) 2017-01-05 2022-12-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア PAC1 receptor agonist (MAXCAP) and use thereof

Also Published As

Publication number Publication date
WO2001085100A2 (en) 2001-11-15
WO2001085100A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU6058500A (en) Fusion protein and uses thereof
AU2001274809A1 (en) Albumin fusion proteins
AU2001291049A1 (en) Defensin-antigen fusion proteins
IL137706A0 (en) Mhc fusion proteins and conjugates
AU3562299A (en) Inhibin-hbc fusion protein
AU2002224866A1 (en) Homocinetic fixed joint
GB9913437D0 (en) Fusion proteins
AUPQ342599A0 (en) Conjugates and uses thereof
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU2001290641A1 (en) Substituted fused pyrroleimines and pyrazoleimines
AU2136401A (en) P450rai-2 and related proteins
AU2002322416A1 (en) Gfp fusion proteins and their use
AU2001275667A1 (en) Homocinetic joint
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU2001261423A1 (en) Vasodilator-thrombolytic fusion proteins and conjugates
AU2002239747A1 (en) Cystoskeleton-associated proteins
IL149202A0 (en) Hedgehog fusion proteins and uses
AU2002229675A1 (en) Selective cytotoxic fusion proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001260633A1 (en) Fas ligand-fused proteins
AU2002211475A1 (en) Site-specific protein modification
AU2002240889A1 (en) Proteins that interact with betatrcp
AU2001241044A1 (en) Mitf-associated proteins
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof